XLRN - Acceleron Pharma Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts10101112
Avg. Estimate-0.82-0.43-2.3-1.93
Low Estimate-0.88-0.88-2.81-2.59
High Estimate-0.68-0.01-1.77-1.2
Year Ago EPS-0.63-0.75-2.59-2.3
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts991011
Avg. Estimate4.65M27.45M61.7M105.4M
Low Estimate2.06M2.1M33.96M70.37M
High Estimate8.71M51.55M90M213.33M
Year Ago Sales3.26M3.82M13.99M61.7M
Sales Growth (year/est)42.70%619.30%341.00%70.80%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.66-0.68-0.59-0.3
EPS Actual-0.63-0.75-0.74-0.34
Difference0.03-0.07-0.15-0.04
Surprise %4.50%-10.30%-25.40%-13.30%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.82-0.43-2.3-1.93
7 Days Ago-0.82-0.43-2.3-1.93
30 Days Ago-0.69-0.56-2.29-1.59
60 Days Ago-0.67-0.53-2.25-1.48
90 Days Ago-0.71-0.59-2.34-1.44
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days3451
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesXLRNIndustrySectorS&P 500
Current Qtr.-30.20%N/AN/A-0.00
Next Qtr.42.70%N/AN/A0.08
Current Year11.20%N/AN/A0.03
Next Year16.10%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A